- Tytuł:
-
Sofosbuvir plus
ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open-label, phase 3 trial. - Autorzy:
- Źródło:
- Journal of viral hepatitis [J Viral Hepat] 2014 Nov; Vol. 21 (11), pp. 762-8. Date of Electronic Publication: 2014 Sep 08.
- Typ publikacji:
- Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
- MeSH Terms:
-
Antiviral Agents/*therapeutic use
Hepatitis C, Chronic/*drug therapyRibavirin /*therapeutic use
Uridine Monophosphate/*analogs & derivatives
Adult ; Aged ; Antiviral Agents/adverse effects ; Drug-Related Side Effects and Adverse Reactions/epidemiology ; Drug-Related Side Effects and Adverse Reactions/pathology ; Female ; Genotype ; Hepacivirus/classification ; Hepacivirus/genetics ; Hepacivirus/isolation & purification ; Hepatitis C, Chronic/virology ; Humans ; Japan ; Male ; Middle Aged ; RNA, Viral/blood ;Ribavirin /adverse effects ; Sofosbuvir ; Treatment Outcome ; Uridine Monophosphate/adverse effects ; Uridine Monophosphate/therapeutic use ; Young Adult
Czasopismo naukowe